Jacek Pinski

3.9k total citations
114 papers, 2.9k citations indexed

About

Jacek Pinski is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Jacek Pinski has authored 114 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Pulmonary and Respiratory Medicine, 37 papers in Oncology and 29 papers in Molecular Biology. Recurrent topics in Jacek Pinski's work include Prostate Cancer Treatment and Research (65 papers), Estrogen and related hormone effects (15 papers) and Prostate Cancer Diagnosis and Treatment (12 papers). Jacek Pinski is often cited by papers focused on Prostate Cancer Treatment and Research (65 papers), Estrogen and related hormone effects (15 papers) and Prostate Cancer Diagnosis and Treatment (12 papers). Jacek Pinski collaborates with scholars based in United States, Japan and Germany. Jacek Pinski's co-authors include Andrew V. Schally, Tanya B. Dorff, David I. Quinn, Susan Groshen, Qingcai Wang, Gábor Halmos, Siamak Daneshmand, Hossein Jadvar, Marcus L. Quek and Jie Cai and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Jacek Pinski

113 papers receiving 2.8k citations

Peers

Countries citing papers authored by Jacek Pinski

Since Specialization

Citations

This map shows the geographic impact of Jacek Pinski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacek Pinski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacek Pinski more than expected).

Fields of papers citing papers by Jacek Pinski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacek Pinski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacek Pinski. The network helps show where Jacek Pinski may publish in the future.

Co-authorship network of co-authors of Jacek Pinski

This figure shows the co-authorship network connecting the top 25 collaborators of Jacek Pinski. A scholar is included among the top collaborators of Jacek Pinski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacek Pinski. Jacek Pinski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A phase I study of intravenous fenretinide (4-HPR) for patients with malignant solid tumors 2021 ·Cancer Chemotherapy and Pharmacology ·Jacob Thomas, Anthony B. El-Khoueiry, Barry J. Maurer, Susan Groshen, Jacek Pinski, Everardo Cobos, David R. Gandara, Heinz Josef Lenz, Min H. Kang, C. Patrick Reynolds, Edward M. Newman	14
2	Phase 2 trial of monoamine oxidase inhibitor phenelzine in biochemical recurrent prostate cancer 2020 ·Prostate Cancer and Prostatic Diseases ·Mitchell E. Gross, David B. Agus, Tanya B. Dorff, Jacek Pinski, David I. Quinn, (unknown), (unknown), Jean C. Shih	42
3	A Phase II Trial of AEZS-108 in Castration- and Taxane-Resistant Prostate Cancer 2017 ·Clinical Genitourinary Cancer ·Steven Yu, (unknown), Stephen V. Liu, Andrew V. Schally, Denice Tsao‐Wei, Susan Groshen, David I. Quinn, Tanya B. Dorff, Shigang Xiong, Jürgen Engel, Jacek Pinski	24
4	Differential Effects of RUNX2 on the Androgen Receptor in Prostate Cancer: Synergistic Stimulation of a Gene Set Exemplified by SNAI2 and Subsequent Invasiveness 2014 ·Cancer Research ·Gillian H. Little, Sanjeev K. Baniwal, Helty Adisetiyo, Susan Groshen, Nyam‐Osor Chimge, (unknown), Omar Khalid, Debra Hawes, Jeremy O. Jones, Jacek Pinski, Dustin E. Schones, Baruch Frenkel	31
5	Phase I, Dose-Escalation Study of the Targeted Cytotoxic LHRH Analog AEZS-108 in Patients with Castration- and Taxane-Resistant Prostate Cancer 2014 ·Clinical Cancer Research ·Stephen V. Liu, Denice Tsao‐Wei, Shigang Xiong, Susan Groshen, Tanya B. Dorff, David I. Quinn, Yu‐Chong Tai, Juergen Engel, Debra Hawes, Andrew V. Schally, Jacek Pinski	37
6	Prospective Evaluation of 18F-NaF and 18F-FDG PET/CT in Detection of Occult Metastatic Disease in Biochemical Recurrence of Prostate Cancer 2012 ·Clinical Nuclear Medicine ·Hossein Jadvar, Bhushan Desai, Lingyun Ji, Peter S. Conti, Tanya B. Dorff, Susan Groshen, Mitchell E. Gross, Jacek Pinski, David I. Quinn	100
7	Effect of luteinizing hormone on the steroidogenic pathway in prostate cancer 2010 ·The Prostate ·Jacek Pinski, Shigang Xiong, Qingcai Wang, Frank Z. Stanczyk, Debra Hawes, Stephen V. Liu	23
8	Phase I Clinical Trial of Pegylated Liposomal Doxorubicin and Docetaxel in Patients With Advanced Solid Tumors 2010 ·American Journal of Clinical Oncology ·Syma Iqbal, Denice Tsao‐Wei, David I. Quinn, Barbara J. Gitlitz, Susan Groshen, Ana M. Aparicio, Heinz Josef Lenz, Anthony B. El-Khoueiry, Jacek Pinski, Agustin A. García	4
9	Oral Fenretinide in Biochemically Recurrent Prostate Cancer: A California Cancer Consortium Phase II Trial 2009 ·Clinical Genitourinary Cancer ·Eric Cheung, Jacek Pinski, Tanya B. Dorff, Susan Groshen, David I. Quinn, C. Patrick Reynolds, Barry J. Maurer, Primo N. Lara, Denice Tsao‐Wei, Przemyslaw Twardowski, Gurkamal Chatta, M. McNamara, David R. Gandara	23
10	Prognostic value of the androgen receptor and its coactivators in patients with D1 prostate cancer. 2008 ·PubMed ·Rintaro Mori, Qingcai Wang, Marcus L. Quek, (unknown), Eric Cheung, Ye Wei, Susan Groshen, Debra Hawes, Shinji Togo, Hiroshi Shimada, Kathleen D. Danenberg, Peter V. Danenberg, Jacek Pinski	8
11	Glucose-regulated protein GRP78 is up-regulated in prostate cancer and correlates with recurrence and survival 2007 ·Human Pathology ·Siamak Daneshmand, Marcus L. Quek, (unknown), Charlotte Lee, Richard J. Côté, Debra Hawes, Jie Cai, Susan Groshen, Gary Lieskovsky, Donald G. Skinner, Amy S. Lee, Jacek Pinski	186
12	Evolving treatment paradigms for locally advanced and metastatic prostate cancer 2006 ·Expert Review of Anticancer Therapy ·Tanya B. Dorff, Marcus L. Quek, Siamak Daneshmand, Jacek Pinski	3
13	Inhibitory effect of IL‐6‐induced neuroendocrine cells on prostate cancer cell proliferation 2004 ·The Prostate ·Qingcai Wang, (unknown), Jacek Pinski	22
14	Inhibition of the growth of caki-I human renal adenocarcinoma in Vivo by luteinizing hormone-releasing hormone antagonist cetrorelix, somatostatin analog RC-160, and bombesin antagonist RC-3940-II 1998 ·Cancer ·A. Jungwirth, Andrew V. Schally, (unknown), Kate Groot, (unknown), Jacek Pinski, Patricia Armatis	27
15	Effect of chronic administration of a new potent agonist of GH-RH(1–29)NH2 on linear growth and GH responsiveness in rats 1996 ·Regulatory Peptides ·Jacek Pinski, Jan Izdebski, A. Jungwirth, Kate Groot, Andrew V. Schally	4
16	Recovery of Pituitary‐Gonadal Function in Male Rats after Long‐Term Suppression Induced by a Single Injection of Microcapsules of LH‐RH Antagonist Cetrorelix (SB‐75) 1993 ·Journal of Andrology ·Jacek Pinski, Tetsu Yano, Károly Szepesházi, Kate Groot, Andrew V. Schally	12
17	Inhibition of growth of experimental prostate cancer in rats by LH‐RH analogs linked to cytotoxic radicals 1993 ·The Prostate ·Jacek Pinski, Andrew V. Schally, Tetsu Yano, Károly Szepesházi, Gábor Halmos, Kate Groot, Ana Maria Comaru‐Schally, Siniša Radulović, (unknown)	20
18	High potency of a new bombesin antagonist (RC-3095) in inhibiting serum gastrin levels; comparison of different routes of administration 1992 ·Regulatory Peptides ·Jacek Pinski, Tetsu Yano, Zoltán Rékási, Renzhi Cai, Siniša Radulović, Andrew V. Schally	11
19	Inhibition of growth of MCF-7 MIII human breast carcinoma in nude mice by treatment with agonists or antagonists of LH-RH 1992 ·Breast Cancer Research and Treatment ·Tetsu Yano, (unknown), Jacek Pinski, Károly Szepesházi, Slobodan Milovanović, Kate Groot, Robert Clarke, Ana Maria Comaru‐Schally, Andrew V. Schally	27
20	Effect of microcapsules of luteinizing hormone‐releasing hormone antagonist SB‐75 and somatostatin analog RC‐160 on endocrine status and tumor growth in the dunning R‐3327H rat prostate cancer model 1992 ·The Prostate ·Tetsu Yano, Jacek Pinski, Károly Szepesházi, Slobodan Milovanović, Kate Groot, Andrew V. Schally	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact